There are no products listed under this category.
ERAS
ERAS (ES cell expressed Ras, also known as HRAS2 or HRASP) is a constitutively active member of the Ras family of small GTPases. It binds GDP and GTP, has intrinsic GTPase activity, and contributes to the tumour-like growth of embryonic stem cells. Browse Assay Genie's current range of ERAS research reagents below, or read on for the biology behind the target.
ERAS is a small GTPase of the Ras family. Like other Ras proteins, it binds GDP and GTP and carries intrinsic GTPase activity. The NCBI Gene summary describes it as constitutively active. UniProt annotates a role in the tumour-like growth properties of embryonic stem cells, and the protein localises to the cell membrane.
According to the NCBI Gene summary, the ERAS protein activates the phosphatidylinositol 3-kinase signal transduction pathway in undifferentiated stem cells. It is not expressed in differentiated cells. This restricted pattern makes the ERAS gene a point of interest for work on stemness and on how stem cell-like growth is maintained.
The gene is named for its expression in embryonic stem (ES) cells. Its previous symbols, HRAS2 and HRASP, and its earlier name, v-Ha-ras Harvey rat sarcoma viral oncogene homolog pseudogene, reflect its similarity to the HRAS gene. HGNC places it in the RAS type GTPase family. UniProt classes the protein in the small GTPase superfamily, Ras family. The gene may be involved in cancer and chemotherapy resistance, so researchers studying ERAS often examine it alongside other Ras signalling components. The mouse ortholog is Eras.
ERAS contributes to the tumour-like growth properties of embryonic stem cells, making it relevant to studies of pluripotency and proliferation.
ERAS activates the phosphatidylinositol 3-kinase pathway in undifferentiated stem cells, so it is studied as an upstream regulator of this cascade.
The ERAS gene may be involved in cancer, and its restricted expression pattern invites comparison between undifferentiated and differentiated states.
NCBI Gene notes a possible role for ERAS in chemotherapy resistance, which makes it a candidate for work on treatment response.
ERAS is a Ras family small GTPase that binds GDP and GTP and has intrinsic GTPase activity. It is constitutively active, activates the phosphatidylinositol 3-kinase pathway in undifferentiated stem cells, and plays an important role in the tumour-like growth properties of embryonic stem cells.
ERAS stands for ES cell expressed Ras, and UniProt names the protein GTPase ERas. Aliases and previous symbols include HRAS2 and HRASP. An earlier gene name was v-Ha-ras Harvey rat sarcoma viral oncogene homolog pseudogene.
NCBI Gene states that ERAS may be involved in cancer and chemotherapy resistance. The protein is not expressed in differentiated cells. A mouse ortholog, Eras, exists; check the datasheet of any product for its validated reactivity.
Other Ras family GTPases and PI3K pathway components that are often studied alongside ERAS in stem cell and cancer research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q7Z444; product specifications from Assay Genie datasheets.
There are no products listed under this category.